Original Research
Published on 09 Jul 2025
Affibody-based targeting agent 131I-YZHER2: V2 for HER2-positive ovarian cancer xenografts
in Nuclear Medicine
- 2,215 views
Original Research
Published on 09 Jul 2025
in Nuclear Medicine
Case Report
Published on 09 Jul 2025
in Nuclear Medicine
Original Research
Published on 04 Jul 2025
in Nuclear Medicine
Original Research
Published on 03 Jul 2025
in Nuclear Medicine
Original Research
Published on 03 Jul 2025
in Nuclear Medicine
Correction
Published on 23 Jun 2025
in Nuclear Medicine
Case Report
Published on 18 Jun 2025
in Nuclear Medicine
Original Research
Published on 11 Jun 2025
in Nuclear Medicine
Case Report
Published on 30 May 2025
in Nuclear Medicine
Original Research
Published on 21 May 2025
in Nuclear Medicine
Original Research
Published on 21 May 2025
in Nuclear Medicine
Case Report
Published on 15 May 2025
in Nuclear Medicine
Original Research
Published on 09 May 2025
in Nuclear Medicine
Case Report
Published on 09 May 2025
in Nuclear Medicine
Original Research
Published on 28 Apr 2025
in Nuclear Medicine
Original Research
Published on 22 Apr 2025
in Nuclear Medicine
Original Research
Published on 07 Apr 2025
in Nuclear Medicine
Original Research
Published on 26 Mar 2025
in Nuclear Medicine
Original Research
Published on 26 Mar 2025
in Nuclear Medicine
Original Research
Published on 17 Mar 2025
in Nuclear Medicine
Original Research
Published on 14 Mar 2025
in Nuclear Medicine
Original Research
Published on 19 Feb 2025
in Nuclear Medicine
Mini Review
Published on 18 Feb 2025
in Nuclear Medicine
Original Research
Published on 13 Feb 2025
in Nuclear Medicine